Table 1.
Baseline Characteristics of the 15 Chronic Pulmonary Study Subjects
| |
---|---|
Age - yr | |
Mean | 54 |
Range | 43–65 |
| |
Sex - number (%) | |
Male | 4 (36) |
Female | 11 (73) |
| |
Race - number (%) | |
African American | 7 (47) |
Caucasian | 8 (53) |
| |
Years since histologic diagnosis | |
Mean | 10 |
Range | 1–32 |
| |
Concominant therapy - no. (%) | 7 (47) |
| |
Corticosteroids only | 3 (20) |
Immunomodulator only | 1 (7) |
Corticosteroids + immunomodulator | 3 (20) |
Corticosteroid dose (mg prednisone equivalent/day) | |
Mean | 13 |
Range | 3.75–30 |
| |
Scadding CXR Stage 0/I/II/III/IV | 1/1/8/3/2 |